APDN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APDN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Applied DNA Sciences's Revenue per Share for the three months ended in Dec. 2024 was $1.90.
During the past 12 months, Applied DNA Sciences's average Revenue per Share Growth Rate was -89.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -67.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -45.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Applied DNA Sciences was 28.70% per year. The lowest was -67.70% per year. And the median was -27.90% per year.
For the Diagnostics & Research subindustry, Applied DNA Sciences's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Applied DNA Sciences's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Applied DNA Sciences (NAS:APDN) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Thank you for viewing the detailed overview of Applied DNA Sciences's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Clay Shorrock | officer: Chief Legal Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Scott L Anchin | director | 16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127 |
William W Montgomery | 10 percent owner | 34211 SEAVEY LOOP RD., EUGENE OR 97405 |
Judith Murrah | officer: Chief Information Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Beth Jantzen | officer: Chief Financial Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Yacov A Shamash | director | |
Robert B Catell | director | 62 OSBORNE ROAD, GARDEN CITY NY 11530 |
John Iii Bitzer | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Joseph D. Ceccoli | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Elizabeth M. Ferguson | director | 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Charles S. Ryan | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
James A Hayward | director, officer: Chief Executive Officer | C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790 |
Karol Gray | officer: Chief Financial Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Ming-hwa Benjamin Liang | officer: Strategic Tech. Dev. Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Yacov Shamash | director | 100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200 |
From GuruFocus
By GuruFocus News • 11-15-2024
By ACCESSWIRE • 07-25-2024
By GuruFocus News • 10-09-2024
By ACCESSWIRE • 01-10-2025
By ACCESSWIRE • 10-15-2024
By ACCESSWIRE • 09-17-2024
By ACCESSWIRE • 08-19-2024
By ACCESSWIRE • 09-11-2024
By ACCESSWIRE • 08-23-2024
By ACCESSWIRE • 02-14-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.